Procter & Gamble (NYSE:PG) Stock Price Target Raised at Citigroup

Procter & Gamble (NYSE:PG – Get Free Report) had its price target lifted by stock analysts at Citigroup from $180.00 to $187.00 in a note issued to investors on Friday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Citigroup‘s price target suggests a potential upside of 15.82% from the stock’s current price.

A number of other research analysts have also commented on the stock. BNP Paribas Exane raised their price objective on shares of Procter & Gamble from $177.00 to $189.00 and gave the company an “outperform” rating in a research note on Friday. Bank of America cut their target price on Procter & Gamble from $170.00 to $166.00 and set a “buy” rating for the company in a research report on Friday, July 10th. Royal Bank Of Canada set a $169.00 price target on Procter & Gamble in a research note on Friday. Barclays lifted their price target on Procter & Gamble from $146.00 to $152.00 and gave the company an “equal weight” rating in a research report on Tuesday, July 21st. Finally, Sanford C. Bernstein reissued a “market perform” rating and issued a $149.00 price objective on shares of Procter & Gamble in a research note on Monday, August 24th. Fourteen equities research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $167.35.

Read Our Latest Research Report on PG

Procter & Gamble Price Performance

PG stock traded down $4.13 during trading on Friday, hitting $161.46. The company had a trading volume of 5,417,172 shares, compared to its average volume of 9,741,831. The business has a 50 day moving average of $148.08 and a 200 day moving average of $146.99. The firm has a market capitalization of $375.03 billion, a price-to-earnings ratio of 24.40, a P/E/G ratio of 3.90 and a beta of 0.39. The company has a current ratio of 0.68, a quick ratio of 0.47 and a debt-to-equity ratio of 0.43. Procter & Gamble has a fifty-two week low of $137.62 and a fifty-two week high of $167.25.

Procter & Gamble (NYSE:PG – Get Free Report) last released its earnings results on Thursday, October 22nd. The company reported $2.00 EPS for the quarter, beating the consensus estimate of $1.89 by $0.11. Procter & Gamble had a net margin of 18.44% and a return on equity of 31.36%. The firm had revenue of $23.28 billion for the quarter, compared to analysts’ expectations of $22.80 billion. During the same quarter last year, the company earned $1.99 EPS. Procter & Gamble’s quarterly revenue was up 4.0% on a year-over-year basis. As a group, research analysts predict that Procter & Gamble will post 6.98 earnings per share for the current year.

Insider Transactions at Procter & Gamble

In other Procter & Gamble news, CAO Matthew Janzaruk sold 359 shares of the company’s stock in a transaction on Monday, August 24th. The stock was sold at an average price of $145.24, for a total value of $52,141.16. Following the transaction, the chief accounting officer owned 1,271 shares of the company’s stock, valued at approximately $184,600.04. This represents a 22.02% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Andre Schulten sold 3,914 shares of the stock in a transaction on Monday, October 5th. The shares were sold at an average price of $145.34, for a total value of $568,860.76. Following the sale, the chief financial officer owned 65,618 shares of the company’s stock, valued at $9,536,920.12. This trade represents a 5.63% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 15,135 shares of company stock valued at $2,189,970 in the last 90 days. 0.23% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Procter & Gamble

Hedge funds and other institutional investors have recently modified their holdings of the stock. BlackRock Inc. acquired a new stake in Procter & Gamble during the 2nd quarter worth about $27,862,105,000. State Street Corp boosted its holdings in shares of Procter & Gamble by 1.0% in the second quarter. State Street Corp now owns 102,216,308 shares of the company’s stock worth $14,988,999,000 after buying an additional 965,461 shares during the period. Bank of America Corp DE acquired a new position in shares of Procter & Gamble in the second quarter worth about $3,850,628,000. Bank of New York Mellon Corp acquired a new position in shares of Procter & Gamble in the second quarter worth about $2,281,505,000. Finally, Dimensional Fund Advisors LP increased its position in shares of Procter & Gamble by 2.6% in the first quarter. Dimensional Fund Advisors LP now owns 11,797,916 shares of the company’s stock worth $1,704,182,000 after acquiring an additional 300,280 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.

Key Headlines Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

  • Positive Sentiment: P&G reported fiscal Q1 adjusted earnings of $2.00 per share and revenue of $23.28 billion, exceeding consensus estimates of $1.89 and $22.80 billion, respectively. Revenue increased 4% year over year. Procter & Gamble earnings beat as sales rise 4%
  • Positive Sentiment: Organic sales growth reaccelerated 4%, with volume contributing 2.4 percentage points. Stronger demand in laundry, home-care and other categories, along with favorable product mix and productivity savings, helped drive the beat.
  • Positive Sentiment: Management raised its fiscal 2027 all-in sales-growth outlook, partly reflecting the Thorne acquisition, while maintaining a roughly $86.0 billion-$87.7 billion revenue range and $6.89-$7.11 EPS guidance. P&G raises FY2027 sales outlook
  • Positive Sentiment: JPMorgan raised its price target from $162 to $180 and upgraded its stance to overweight, indicating confidence that resilient volumes and improving operating leverage can support further appreciation.
  • Neutral Sentiment: TD Cowen increased its target from $150 to $166 but retained a hold rating, signaling limited upside at the current valuation. P&G trades at approximately 24 times earnings, making sustained growth important for additional gains.
  • Negative Sentiment: Higher commodity, energy, transportation and fuel costs are expected to pressure fiscal-year profit by roughly $1.4 billion. Analysts also noted that margins remain under strain despite pricing, productivity measures and favorable mix. P&G flags bigger profit hit from commodity costs
  • Negative Sentiment: The company’s revenue guidance range remains below the roughly $88.8 billion analyst consensus, and investors still face uncertainty over whether volume growth can offset inflationary costs through the rest of fiscal 2027.

Procter & Gamble Company Profile

(Get Free Report)

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.

Recommended Stories

Analyst Recommendations for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.